Alpine Immune Sciences, Inc. is a development-stage pharmaceutical company, which engages in the discovering of protein-based immunotherapies therapies targeting the immune synapse to treat cancer, autoimmune, and inflammatory disorders. It offers Immunotherapy, Immune Synapse, vIgD Platform Technology, and TIP Program. The company was founded in 2015 and is headquartered in Seattle, WA.
SHORT INTEREST
22.54K 08/15/19
P/E Current
-1.86
P/E Ratio (with extraordinary items)
-1.92
Average Recommendation: BUY
Average Target Price: 13.50
SHORT INTEREST
22.54K 08/15/19
P/E Current
-1.86
P/E Ratio (with extraordinary items)
-1.92
Average Recommendation: BUY
Average Target Price: 13.50
⭐⭐⭐ Sign Up for Free ⭐⭐⭐
1) Download our Mobile App >>
Android: dexwirenews.com/APP
Apple: dexwirenews.com/iOS
2) Join our Telegram >> t.me/DEXWireNews
3) Follow @DEXWireNews on Social Media
1) Download our Mobile App >>
Android: dexwirenews.com/APP
Apple: dexwirenews.com/iOS
2) Join our Telegram >> t.me/DEXWireNews
3) Follow @DEXWireNews on Social Media